Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Revenue (2024 - 2026)

Rallybio's Revenue history spans 2 years, with the latest figure at $222000.0 for Q4 2025.

  • On a quarterly basis, Revenue rose 484.21% to $222000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $858000.0, a 34.91% increase, with the full-year FY2025 number at $858000.0, up 34.91% from a year prior.
  • Revenue hit $222000.0 in Q4 2025 for Rallybio, up from $212000.0 in the prior quarter.
  • Over the last five years, Revenue for RLYB hit a ceiling of $299000.0 in Q2 2024 and a floor of $38000.0 in Q4 2024.